Formulation and Development of Gastroretentive Hydrogels of Glipizide
Abstract
Abstract
The aim of the present study was to develop a pH sensitive gastroretentive drug delivery system for an antidiabetic drug glipizide, based on gas formation technique using 32-factorial design, in order to prolong the gastric residence time and increase the overall bioavailability of the dosage form, since the absorption is erratic in diabetic patients. The system consists of the drug, glycol chitosan (5% w/w) and aqueous PVA solution (10% w/w) which were mixed together and pH was adjusted to 4.5–5.0. Then the crosslinking agent (10% aqueous glyoxal) was added, followed by sodium bicarbonate which acts as foaming agent. In acidic environment, superporous hydrogels showed higher swelling ratio because of the cationization of amine groups. The presence of PVA and increased levels of crosslinker significantly improved the mechanical strength of the superporous hydrogels. The drug release studies showed that sustained release of drug could be achieved with high crosslink density and higher amount of PVA.
Keywords: Hydrogels, pH sensitive, gastroretentive, glipizide, factorial design
Cite this Article
Vasanth Samaga, Puranik SB. Formulation and Development of Gastroretentive Hydrogels of Glipizide. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2017; 4(1): 1–7p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)
1. ________________
2. _______________
_3. ________________
4. ________________
The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
